Nancy Reau to Non-alcoholic Fatty Liver Disease
This is a "connection" page, showing publications Nancy Reau has written about Non-alcoholic Fatty Liver Disease.
Connection Strength
2.200
-
Patients With Autoimmune Hepatitis and Nonalcoholic Fatty Liver Disease: Characteristics, Treatment, and Outcomes. J Clin Gastroenterol. 2024 Jan 01; 58(1):91-97.
Score: 0.905
-
An international survey on patterns of practice in NAFLD and expectations for therapies-The POP-NEXT project. Hepatology. 2022 12; 76(6):1766-1777.
Score: 0.805
-
Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journals. Hepatology. 2023 Dec 01; 78(6):1680-1681.
Score: 0.224
-
Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journals. Hepatol Commun. 2023 Nov 01; 7(11).
Score: 0.224
-
Hepatitis C remains leading indication for listings and receipt of liver transplantation for hepatocellular carcinoma. Dig Liver Dis. 2020 01; 52(1):98-101.
Score: 0.042